Protocol Citation: Jessica E. Manning, Jennifer Bohl, Sreyngim Lay, Sophana Chea, Vida Ahyong, Erik Karlsson 2020. SARS-CoV-2 Enrichment Sequencing by Spiked Primer MSSPE method. protocols.io https://dx.doi.org/10.17504/protocols.io.beshjeb6
License: This is an open access protocol distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited
Protocol status: Working
We use this protocol and it's working
Created: April 07, 2020
Last Modified: April 07, 2020
Protocol Integer ID: 35369
Abstract
This protocol was used to enrich for SARS-CoV2 sequencing reads from a confirmed COVID-19 swab sample and attain the full genome using an iSeq100. By using a spiked primer approach with 73 primers spanning the entire SARS-CoV2 genome, we were able to get an average of 15x genome coverage on an iSeq100 with 1.8 million paired end-reads. Here we overview all the steps, from sample extraction, library preparation with a spiked primer enrichment step, and sequencing on an iSeq100. The collaborative effort involved the Manning Lab, NIAID in Phnom Penh, Cambodia, Institut Pasteur Cambodge, Cambodia Ministry of Health, the Chan Zuckerberg Biohub, and the Chan Zuckerberg Initiative.
NEBNext Ultra II RNA Library Prep Kit for Illumina - 96 rxnsNew England BiolabsCatalog #E7770L
High Sensitivity D5000 ScreenTapeAgilent TechnologiesCatalog #5067-5592
Sample Collection
Sample Collection
Nasopharyngeal and oropharyngeal swabs (combined into one tube) were collected from a symptomatic patient meeting case definition for possible infection with SARS-CoV-2.
RNA extraction
RNA extraction
Extraction of viral nucleic acids from clinical sample was performed with a QIAamp Viral RNA Mini Kit (Qiagen #52906) as described by manufacturer
QIAamp® Viral RNA Mini QiagenCatalog #52906
Extracted RNA samples were DNAse-treated using the Zymo DNAse I kit.
DNase I SetZymo ResearchCatalog #E1010
The nucleic acid was tested via real-time polymerase chain reaction for COVID-19 using both the Drosden and HKU protocols published by the World Health Organization and confirmed positive for COVID-19 on January 27th, 2020.
Ct values for PUI = 24.
RNA Quantification
RNA Quantification
RNA was quantified using the Qubit High Sensitivity RNA kit as described by the manufacturer.
Library Preparation was performed with the NEBNext Ultra II non-directional RNA kit.
NEBNext Ultra II RNA Library Prep Kit for Illumina - 96 rxnsNew England BiolabsCatalog #E7770L
Fragmentation & SARS-CoV-2 primer spike in
We incorrectly believed the random primers were at a concentration of 10 μM.
According to NEB, random primers in the NEBNext Ultra II non-directional library preparation protocol are at a concentration of 1.9mM. We had a successful enrichment by adding a 1:1 volume of 100 μM SARS-CoV-2 primers, an approximate 20:1 ratio of random primers to CoV primers. We have not yet tried other ratios.
1 reaction
Reagent
vol stock (uL)
RNA (sample) (10ng – 100ng total)
3.5
25pg ERCC Spike-in (50pg/uL stock) *
0.5
(pink) First SS Reaction Buffer 5x
4
(pink) Random Primers/Spiked primer mix
1
QIAseq FastSelect (1:100) rRNA**
1
Total volume
10
uL/rxn
* (optional) ERCCs are internal synthetic RNA controls comprised of 92 synthetic RNAs that do not match to any known microbe in the NCBI NR/NT databases.
** (optional) FastSelect is designed for removing human rRNA, omit this reagent if not using human derived samples and only incubate at 94°C and then directly to 4°C (omit ramping down steps).
8 min at 94°C (Adjust this fragmentation time depending on the quality of extracted RNA)
2 min 75°C
2 min 70°C
2 min 65°C
2 min 60°C
2 min 55°C
5 min 37°C
5 min 25°C
The 73 primers tile across the entire SARS-CoV2 genome at a spacing of ~400bp.
The PDF below shows the approximate location of the primer binding sites.
enrichmentprimers.pdf
Name
Sequence
Primer_CoV1
GTGACTTCCATGCCAATG
Primer_CoV2
CTGATTTTGGGGTCCATTATC
Primer_CoV3
GAAATGGTGAATTGCCCTC
Primer_CoV4
GATAGCAATTCCACCGGTG
Primer_CoV5
CAGTATAACCACCAATCTG
Primer_CoV6
CATTAATGCCAGAGATGTC
Primer_CoV7
GTATTTGTAATGCAGCAC
Primer_CoV8
CTTCTGTGCAGTTAACATC
Primer_CoV9
GATTCTGTTGGTTGGAC
Primer_CoV10
GAATGTAAAACTGAGGATCTG
Primer_CoV11
CAGCTGTACCTGGTGCAAC
Primer_CoV12
CACTACCTTCTGTAATAAG
Primer_CoV13
CATACAAACTGCCACCATC
Primer_CoV14
GTCCTTTGTACATAAGTG
Primer_CoV15
GAGCTGATTTGTCTTTATGTG
Primer_CoV16
CAGCATCACCATAGTCAC
Primer_CoV17
CGAACCGTTCAATCATAAG
Primer_CoV18
CACCATAGAATTTGCTTGTTC
Primer_CoV19
CTAGCTCTCTGAAGTGGTATC
Primer_CoV20
GTTTCTTCATGTTGGTAG
Primer_CoV21
CTAGCCCATTTCAAATCCTG
Primer_CoV22
GTTGTCCAGCATTTCTTCAC
Primer_CoV23
GACAAACTAGTATCAACCATATC
Primer_CoV24
CTGTCCTGGTTGAATGCGAAC
Primer_CoV25
CAGAGTACAGTGAATGAC
Primer_CoV26
GTAGATGCTATGTCACGAG
Primer_CoV27
GAACCTTTAGTGTTATTAG
Primer_CoV28
GTTCAAATAGCCTTCTCTG
Primer_CoV29
CTTAAAAGAGGGTGTGTAG
Primer_CoV30
CTCACCTACTGTCTTATTAC
Primer_CoV31
CATTTAGATCGTTAAGTGTG
Primer_CoV32
GTGCGAACAGTATCTACAC
Primer_CoV33
CACAACACAGGCGAACTC
Primer_CoV34
CACCTTCCTTAAACTTCTC
Primer_CoV35
CTTCTGAATTGTGACATGCTG
Primer_CoV36
GTCTCACCACTACGACCG
Primer_CoV37
GTTCACGGCAGCAGTATACACC
Primer_CoV38
TCCACAAAAGCACTTGTGGAAGC
Primer_CoV39
TGTGGGAAGTGTTTCTCCCTC
Primer_CoV40
GTCTGAACAACTGGTGTAAGTTCC
Primer_CoV41
ATTTCAGTAGTGCCACCAGCC
Primer_CoV42
CATGTCCACAACTTGCGTGTG
Primer_CoV43
AGCACCGTCTATGCAATACAAAG
Primer_CoV44
ACAGCAGCTAAACCATGAGTAGC
Primer_CoV45
ACAACCGTCTACAACATGCAC
Primer_CoV46
GTCACGGGGTGTCATGTTTTC
Primer_CoV47
CGTGTGTCAGGGCGTAAACTTTC
Primer_CoV48
GAGCCTTTGCGAGATGACAAC
Primer_CoV49
AACGGCAATTCCAGTTTGAGC
Primer_CoV50
GCGGTTGAGTAAACAAAAGAGGC
Primer_CoV51
GGGAACACAACCATCTCTTGC
Primer_CoV52
ACGATGCACCACCAAAGGATTC
Primer_CoV53
AATACCAGCATTTCGCATGGCA
Primer_CoV54
TAGCAGCATTACCATCCTGAGC
Primer_CoV55
TGCATTAACATTGGCCGTGAC
Primer_CoV56
ACAACCTGGAGCATTGCAAAC
Primer_CoV57
TCACATAGTGCATCAACAGCGG
Primer_CoV58
TAAAGTTGCCACATTCCTACGTGG
Primer_CoV59
TAACAAAGCACTCGTGGACAGC
Primer_CoV60
CCTGTTGTCCATCAAAGTGTCCC
Primer_CoV61
GATGAACCTGTTTGCGCATCTG
Primer_CoV62
CTATTTGTTCGCGTGGTTTGCC
Primer_CoV63
ACCCTGTTTTCCTTCAAGGTCC
Primer_CoV64
TGCTACCGGCCTGATAGATTTC
Primer_CoV65
TGCTGCATTCAGTTGAATCACC
Primer_CoV66
CAGAAGCTCTGATTTCTGCAGC
Primer_CoV67
TTGCAGTAGCGCGAACAAAATC
Primer_CoV68
ACGCACACAATCGAAGCGCAG
Primer_CoV69
TGCCAATCCTGTAGCGACTGTATGC
Primer_CoV70
AGGACACGGGTCATCAACTAC
Primer_CoV71
TGCCAGCCATTCTAGCAGGAG
Primer_CoV72
TGTGGTGGCTCTTTCAAGTCC
Primer_CoV73
TTTTGTCATTCTCCTAAGAAGC
Enrichment primer sequences for SARS-CoV-2 genome
First Strand Synthesis
Mix the following by pipetting up and down.
1 rxn
Reagent
vol stock (uL)
Fragmented & primed RNA
10
Nuclease-free water
8
(pink) NEBNext First Strand Synthesis Enzyme Mix
2
Total volume
20 uL/rxn
Thermocycler (heated lid set to 105°C):
10 mins at 25°C
15 mins at 42°C
15 mins at 70°C
Hold at 4°C
Second Strand Synthesis
1 rxn
Reagent
vol stock (uL)
First strand synthesized DNA
20
(orange) 2nd SS Reaction buffer (10X)
8
(orange) 2nd SS enzyme mix
4
Nuclease-free water
48
Total volume
80 uL/rxn
Thermocycler (heated lid off):
1 hour at 16°C
Hold at 4°C
SPRI cleanup
*allow beads to sit in RT for 30 mins prior
Use SPRI Beads1.8x ratio of beads-to-total volume of sample. Prep 80% EtOH.
Add 144uL of room temperature beads to 2nd Strand Synthesis Rxn. Mix well by pipetting gently.
Pulse spin the tubes, but be sure not to spin down beads. Incubate for 5 mins at room temperature.
Place samples on magnetic rack, and incubate for 5 mins on the rack.
Remove supernatant.
Add 200uL of 80% EtOH to samples while on the magnetic rack. Incubate at room temperature for 30s then remove the supernatant.
Repeat EtOH wash step for a total of 2 timess
Air dry the beads for 5 mins while on the magnetic rack.
Remove tube from magnetic rack. Elute DNA from beads into 53uL of 0.1x TE Buffer, 10mM Tris-HCl, or Nuclease free water.
Vortex to mix. Spin tubes and incubate for 2 mins at room temperature off the magnetic rack.
Place on magnetic rack until solution is clear ~ 5 mins.
Remove 50uL of the supernatant and transfer to a clean nuclease free PCR tube.
**Checkpoint: Samples can be stored frozen at -20 °C and library prep resumed the next day.
End Repair
Mix all the following by pipetting up and down
1 rxn
Reagent
vol stock (uL)
Purified ds-cDNA
50
(green) Ultra II End Prep reaction buffer (8.6x)
7
(green) Ultra II End Prep enzyme mix
3
Total volume
60 uL/rxn
Thermocycler (heated lid set to 105°C):
30 mins at 20°C
30 mins at 65°C
Hold at 4°C
Adapter Ligation
dilute adaptor to dilution prior to making master mix. Adaptor concentration depends on the amount of input; 1:100 dilution for samples <5ng, 1:25 for input of >5ng
Add adaptor separately after ligation master mix and ligation enhancer to avoid adaptor dimers.
1 rxn
Reagent
vol stock (uL)
End Prep reaction mixture
60
(red) NEBNext Ultra II ligation master mix
30
(red) NEBNext ligation enhancer
1
1:100 Adaptor (Cat No. E7337AA)
2.5
Total volume
93.5 uL/rxn
Thermocycler (heated lid off):
15 mins at 20°C with heated lid off
Proceed immediately to Bead Purification.
SPRI Cleanup
*allow beads to sit in RT for 30 mins prior
Use SPRI bead 0.9x ratio of beads-to-total volume of sample. Prep 80% EtOH.
Add 87uL of room temperature beads (0.9x) to Adaptor Ligation reaction. Mix well.
Pulse spin the tubes, but be sure not to spin down beads. Incubate for 5 mins at room temperature.
Place samples on magnetic rack, and incubate for 5 mins on the rack.
Remove supernatant.
Add 200uL of 80% EtOH to samples while on the magnetic rack. Incubate at room temperature for 30s then remove the supernatant.
Repeat EtOH wash step for a total of 2 times.
Air dry the beads for 5 mins while on the magnetic rack.
Remove tube from magnetic rack. Elute DNA from beads into 17uL of 0.1x TE Buffer, 10mM Tris-HCl, or Nuclease free water.
Vortex to mix. Spin tubes and incubate for 2 mins at room temperature off the magnetic rack.
Place on magnetic rack until solution is clear ~ 5 mins.
Remove 15uL of the supernatant and transfer to a clean nuclease free PCR tube.
**Checkpoint: Samples can be stored frozen at -20 °C and library prep resumed the next day.
USER/Q5 Indexing PCR
Mix the following components by pipetting up and down.
*Technical Note from NEB: The TruSeq adaptor and primer strategy from Illumina uses a barcoded adaptor and universal primer. If someone used the universal NEBNext adaptor and Illumina TruSeq universal primer, the result would be a lack of amplification. It is of course possible to use non- NEB adaptors and primers. We support it and we do have an FAQ about this: https://www.neb.com/faqs/2019/03/08/can-i-use-this-nebnext-kit-with-adaptors-and-primers-from-other-vendors-than-neb
** In this new version, we have reduced the purified, adaptor-ligated cDNA to 12uL rather than 15uL to assure that the reaction is not underbuffered. Alternatively, the previous SPRI reaction can concentrate the cDNA further prior to setting up the PCR reaction.
1 rxn
Reagent
vol stock (ul)
Purified, adaptor-ligated cDNA
12**
(white) USER Enzyme (Cat no. M5505L,
250uL)
3
(blue) NEBNext Ultra II Q5 master mix
25
5uM i7 barcoded primer (NEB index
primer/TruSeq/or similar)*
5uL
5uM i5 barcoded primer (NEB Universal
primer/TruSeq/or similar)*
5uL
Total volume
50uL
Cycling conditions:
Thermocycler (heated lid at 105°C):
Cycles
37 °C for 15 mins
1
98 °C for 30s
1
98 °C for 10s
6-15**
65 °C for 75s
65 °C for 5 mins
1
Hold at 4 °C
** PCR cycles are dependent on the input RNA. For libraries with <5ng input, perform 15-19 cycles of PCR. For 5-20ng input, perform 10-14 cycles of PCR. For >20ng input, perform 6-8 cycles of PCR.
SPRI Cleanup
*allow beads to sit in RT for 30 mins prior
Use SPRI Beads at 0.8x ratio of beads-to-total volume of sample. Prep 80% EtOH.
Add 43uL of room temperature Ampure Beads (0.8x) to barcoded DNA. Mix well.
Pulse spin the tubes, but be sure not to spin down beads. Incubate for 5 mins at room temperature.
Place samples on magnetic rack, and incubate for 5 mins on the rack.
Remove supernatant.
Add 200uL of 80% EtOH to samples while on the magnetic rack. Incubate at room temperature for 30s then remove the supernatant.
Repeat EtOH wash step for a total of 2 times.
Air dry the beads for 5 mins while on the magnetic rack.
Remove tube from magnetic rack. Elute DNA from beads into 23uLof 0.1x TE Buffer, 10mMTris-HCL, or Nuclease free water.
Vortex to mix. Spin tubes and incubate for 2 mins at room temperature off the magnetic rack.
Place on magnetic rack until solution is clear ~ 5 mins.
Remove 20uL of the supernatant and transfer to a clean nuclease free PCR tube.
** Checkpoint: Libraries are complete, samples can be stored frozen at -20 °C until ready for quantification and pooling.
Library Quality Control
Library Quality Control
Libraries were quantified by the Qubit High Sensitivity DNA kit and the Agilent High Sensitivity D500 DNA Tapestation assay. If adapter dimers are found, library should be size selected using a SPRI ratio of 0.8x.
High Sensitivity D5000 ScreenTapeAgilent TechnologiesCatalog #5067-5592
Expected result
Tapestation HS D5000 assay shows an average size library of 384bp at a concentration of 62.5 nM.
Quantified library is then diluted down to the loading concentration for the iSeq, 100pM. This value will vary depending on the type of sequencer.
iSeq Loading
iSeq Loading
The Illumina iSeq was loaded with 20uL of a 100pM library with a 5% PhiX spike in.
Analyses
Analyses
Metagenomic sequencing results were uploaded onto IDseq.net directly from the Illumina Basespace Sequence Hub. The open-source cloud-based pipeline analyzed 1.8 million reads. The majority of reads mapped to the nasal and oral microbiome. Analyses of the viral components resulted in 3,077 single end reads aligning to the SARS-CoV2 taxon.
Expected result
Resulting reads from the Betacoronovirus genus were downloaded from IDseq and mapped to the NCBI genome accession number: MN908947.1. The geneious alignment displayed even coverage across the genome with an average coverage of 14.9x. One SNP was noted at position 25,654 in ORF3a resulting in a valine to leucine substitution when compared to NCBI accession MN908947.1.